Clinical Trial Update: A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin [Phase 1]

View source ↗

Summary

Phase 1 trial update on subcutaneous administration of NNC0537-1482 in healthy volunteers. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• NNC0537-1482

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Heart Failure | Phase 1 | Status: COMPLETED